Karuna Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference
June 03 2020 - 6:30AM
Business Wire
Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative
clinical-stage biopharmaceutical company committed to developing
novel therapies with the potential to transform the lives of people
with disabling and potentially fatal neuropsychiatric disorders and
pain, today announced that Steve Paul, M.D., chief executive
officer, president and chairman of Karuna Therapeutics, will
participate in a fireside chat at the virtual Goldman Sachs Annual
Global Healthcare Conference on Thursday, June 11, 2020 at 10:30
a.m. EDT.
A live webcast of the fireside chat will be available on the
Investor Relations page of Karuna’s website at
investors.karunatx.com. A replay of the webcast will also be
archived for up to 90 days on Karuna’s website following the
conference.
About Karuna
Karuna is a clinical-stage biopharmaceutical company committed
to developing and delivering first-in-class therapies with the
potential to transform the lives of people with CNS disorders –
which remain among the most disabling and potentially fatal
disorders worldwide. Galvanized by the understanding that today’s
neuropsychiatric and pain management patients deserve better,
Karuna’s mission is to harness the untapped potential of the
brain’s complex biology in pursuit of novel therapeutic pathways
that will advance the standard of care. For more information,
please visit karunatx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200603005124/en/
Investor Contact: Alexis Smith 518-338-8990
asmith@karunatx.com
Media Contact: Jenn Gordon GlobalHealthPR 202-587-2580
jgordon@globalhealthpr.com
Karuna Therapeutics (NASDAQ:KRTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Karuna Therapeutics (NASDAQ:KRTX)
Historical Stock Chart
From Apr 2023 to Apr 2024